Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 14;77(3):490-491.
doi: 10.1093/cid/ciad162.

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle

Katherine E Atkins  1   2 , David Hodgson  2
Affiliations
Editorial

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle

Katherine E Atkins et al. Clin Infect Dis. .
No abstract available

Keywords: duration of vaccine protection; elderly vaccination; mathematical modelling.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. K. E. A. reports honoraria from the Institute for Global Health University College London as an External Examiner, and unpaid participation on a grant selection committee and travel support for meetings from the Wellcome Trust. D. H. reports no potential conflicts. Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Comment on

References

    1. Shi T, Denouel A, Tietjen AK, et al. . Global disease burden estimates of respiratory syncytial virus–associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis. J Infect Dis 2020; 222:S577–83. - PubMed
    1. PATH . RSV vaccine and mAb snapshot. Available at: https://media.path.org/documents/RSV-Snapshot_03JAN2023_HighResolution.pdf. Accessed 10 March 2023.
    1. van Effelterre T, Hens H, White LJ, et al. . Modeling respiratory syncytial virus adult vaccination in the United States with a dynamic transmission model. Clin Infect Dis 2023; 77:480–9. - PubMed
    1. Hodgson D, Pebody R, Panovska-Griffiths J, Baguelin M, Atkins KE. Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis. BMC Med 2020; 18:348. - PMC - PubMed
    1. GlaxoSmithKline. GSK's older adult respiratory syncytial virus (RSV) vaccine candidate shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial. 2022. Available at: https://www.gsk.com/en-gb/media/press-releases/gsk-s-older-adult-respira.... Accessed 9 March 2023.

MeSH terms